AGE OF DISCOVERY

16 18 April 2010, Lisbon, Portugal

Arterial Thrombosis Venous Thrombosis

Case Studies Debates International Faculty Poster Maze

AGE OF DISCOVERY
16 18 April 2010, Lisbon, Portugal

AGENDA

Chairmen Harry R Bller, MD, PhD

Professor of Medicine, Chairman, Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

Friday 16 April 2010 Faculty and Delegate Arrivals

Lord Kakkar, MD, PhD, FRCS

Professor of Surgical Sciences and Dean for External Relations, Barts and the London School of Medicine and Dentistry; Director, Thrombosis Research Institute, London, United Kingdom

Saturday 17 April 2010 08.45 10.25 Plenary Session I 08.45 08.55 Opening Remarks H Bller, The Netherlands (Co-Chair) State of the Art VTE Prevention Lord Kakkar, UK (Co-Chair) VTE Treatment H Bounameaux, Switzerland Arterial Thrombosis L Wallentin, Sweden

Auditorium I

ARTERIAL TRACK Stroke Prevention/Atrial Fibrillation Directors: Stuart J Connolly, MD, FRCPC
Director of the Division of Cardiology, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada

08.55 09.25 09.25 09.55 09.55 10.25 10.25 11.00 11.00 13.00

Gregory YH Lip, MD, FRCP, FESC, FACC

Professor of Cardiovascular Medicine, Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

Coffee Break Core-Track Session I Arterial Track Stroke Prevention/Atrial Fibrillation Venous Track VTE Prophylaxis and Treatment Venous Track VTE Prophylaxis in Orthopaedic Surgery Auditorium I Auditorium VIII Auditorium VI & VII Pavilion 1 Pavilion 2

VENOUS TRACK VTE Prophylaxis and Treatment Directors: Paolo Prandoni, MD, PhD
Director, Thromboembolism Unit, University of Padua, Padua, Italy

13.00 14.30 14.30 16.45 16.45 18.30

Lunch Core-Track Session II Poster Maze and Welcome Reception

Jeffrey Weitz, MD, FRCP(C), FACP

Professor of Medicine and Biochemistry, McMaster University; Director, Henderson Research Centre, Hamilton, Canada

VENOUS TRACK VTE Prophylaxis in Orthopaedic Surgery Directors: Fred Cushner, MD

Director, Insall Scott Kelly Institute, NY, NY; Chairman, Division of Orthopedic Surgery, Southside Hospital, Bay Shore, NY; Assistant Clinical Professor, Albert Einstein School of Medicine, NY, NY, United States

Sunday 18 April 2010 08.45 10.15 10.15 11.00 11.00 13.00 11.00 12.00 12.00 12.45 Core-Track Session III Coffee Break* Plenary Session II Meet the Principal Investigators Debate: Net Clinical Benefit is Meaningless For: P Mismetti, France Against: J Eikelboom, Canada Closing Remarks Lord Kakkar, UK Lunch Pavilion 1 Auditorium I

Patrick Mismetti, MD, PhD

Professor, Clinical Pharmacologist, Vascular Medicine and Stroke Unit, University of Saint-Etienne, St-Etienne, France

12.45 13.00 13.00 14.00

* The Poster Maze will be available at this time in Pavilion 2

Sponsored with an educational grant from Boehringer Ingelheim.

AGE OF DISCOVERY
16 18 April 2010, Lisbon, Portugal

ARTERIAL TRACK AGENDA

Directors: Stuart J Connolly, MD, FRCPC
Director of the Division of Cardiology, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada

STROKE PREVENTION/ATRIAL FIBRILLATION

Saturday 17 April 2010 11.00 13.00 11.00 11.05 11.05 11.35 Arterial Track Session I: Stroke Prevention/Atrial Fibrillation Welcome and Introduction GYH Lip, UK (Co-Director) Pathophysiology of Thromboembolism in Atrial Fibrillation A Cohen, France How Clinical Trials Have Changed Management of AF: Insights into Methodology C Granger, USA Stroke Risk Factors and Risk Assessment: An Evolution or a Revolution? GYH Lip, UK Panel Question-and-Answer Session Lunch Arterial Track Session II: Stroke Prevention/Atrial Fibrillation Whats New for Stroke Prevention in AF? S Connolly, Canada (Co-Director) Debate 1: Less Guidelines and More Common Sense is Needed for the Management of AF For: P Kirchhof, Germany Against: C Granger, USA Debate 2: Over the Next 5 Years the Use of All Warfarin Will Diminish For: E Hylek, USA Against: D Fitzmaurice, UK Panel Question-and-Answer Session Pavilion 1 Auditorium I Auditorium I

Gregory YH Lip, MD, FRCP, FESC, FACC

Professor of Cardiovascular Medicine, Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

11.35 12.10

12.10 12.45

12.45 13.00 13.00 14.30 14.30 16.45 14.30 15.10 15.10 15.45

15.45 16.20

16.20 16.45

Sunday 18 April 2010 08.45 10.15 08.45 09.15 Arterial Track Session III: Stroke Prevention/Atrial Fibrillation Treating Hypertensive Patients with Atrial Fibrillation M Bhm, Germany Clinical Cases: 09.15 09.35 1) Rhythm Control, Rate Control Presenter: A Krahn, Canada Discussant: S Connolly, Canada Chair: GYH Lip, UK 2) Stroke Prevention in AF Presenter: G Flaker, USA Discussant: D Lane, UK Chair: GYH Lip, UK 3) Co-morbidities and AF (ablation, co-morbidities) Presenter: R Cappato, Italy Discussant: KH Kuck, Germany Chair: S Connolly, Canada Auditorium I

09.35 09.55

09.55 10.15

Sponsored with an educational grant from Boehringer Ingelheim.

AGE OF DISCOVERY
16 18 April 2010, Lisbon, Portugal

VENOUS TRACK AGENDA

Directors: Paolo Prandoni, MD, PhD
Director, Thromboembolism Unit, University of Padua, Padua, Italy

VTE PROPHYLAXIS AND TREATMENT

Saturday 17 April 2010 11.00 13.00 11.00 11.05 11.05 11.35 11.35 12.05 Venous Track Session I: VTE Prophylaxis and Treatment Welcome and Introduction J Weitz, Canada (Co-Director) VTE Pathophysiology/Natural History A Review S Haas, Germany Methodological Aspects for Trials in VTE Prevention and Treatment M Prins, The Netherlands Whats New in VTE Treatment Building on the Foundation of Data S Schulman, Canada Panel Question-and-Answer Session Lunch Venous Track Session II: VTE Prophylaxis and Treatment Whats New in VTE Prophylaxis? G Agnelli, Italy Knowledge Translation: Application of Existing Data R Arya, UK Debate 1: New Oral Agents Should Be Given to All VTE Patients For: M Huisman, The Netherlands Against: J Weitz, Canada Debate 2: All Patients With Unprovoked VTE Should Receive Long-Term Anticoagulant Therapy For: C Kearon, Canada Against: B Cosmi, Italy Panel Question-and-Answer Session Pavilion 1 Auditorium VIII Auditorium VIII

Jeffrey Weitz, MD, FRCP(C), FACP

Professor of Medicine and Biochemistry, McMaster University; Director, Henderson Research Centre, Hamilton, Canada

12.05 12.35

12.35 13.00 13.00 14.30 14.30 16.45 14.30 14.50 14.50 15.10 15.10 15.45

15.45 16.10

16.10 16.45

Sunday 18 April 2010 08.45 10.15 Venous Track Session III: VTE Prophylaxis and Treatment Clinical Cases: 08.45 09.15 09.15 09.45 09.45 10.15 1) Impact of Bleeding in the VTE Setting Presenter: J Eikelboom, Canada 2) Reducing the Risk of Long-term Complications of VTE Presenter: P Prandoni, Italy (Co-Director) 3) VTE Treatment in Special Populations Presenter: S Middeldorp, The Netherlands Auditorium VIII

Sponsored with an educational grant from Boehringer Ingelheim.

AGE OF DISCOVERY
16 18 April 2010, Lisbon, Portugal

VENOUS TRACK AGENDA

Directors: Fred Cushner, MD
Director, Insall Scott Kelly Institute, NY, NY; Chairman, Division of Orthopedic Surgery, Southside Hospital, Bay Shore, NY; Assistant Clinical Professor, Albert Einstein School of Medicine, NY, NY, United States

VTE PROPHYLAXIS IN ORTHOPAEDIC SURGERY

Saturday 17 April 2010 11.00 13.00 Venous Track Session I: VTE Prophylaxis in Orthopaedic Surgery 11.00 11.05 Welcome and Introduction P Mismetti, France (Co-Director) 11.05 11.35 11.35 12.15 12.15 12.45 12.45 13.00 13.00 14.30 14.30 16.45 14.30 15.00 15.00 15.45

Auditorium VI & VII

Patrick Mismetti, MD, PhD

Professor, Clinical Pharmacologist, Vascular Medicine and Stroke Unit, University of Saint-Etienne, St-Etienne, France

VTE Prophylaxis for Orthopaedics in the 21st Century M Nett, USA Methodological Aspects for Trials in VTE Prophylaxis R Hull, Canada Orthopaedic Surgery: Priorities and Perspectives F Cushner, USA (Co-Director) Panel Question-and-Answer Session Lunch Venous Track Session II: VTE Prophylaxis in Orthopaedic Surgery Pavilion 1 Auditorium VI & VII

Preventing Complications in Total Joint Arthroplasty B Eriksson, Sweden Debate 1: There is No Need for Pharmaceuticals: Long Live SCDs! For: B Violante, Italy Against: D Warwick, UK Debate 2: LMWH Will Remain the Standard of Care For: N Rosencher, France Against: A Spyropoulos, Canada Panel Question-and-Answer Session

15.45 16.30

16.30 16.45

Sunday 18 April 2010 08.45 10.15 Venous Track Session III: VTE Prophylaxis in Orthopaedic Surgery 08.45 09.15 Individualized VTE Prophylaxis: Risk Factors for VTE and Bleeding P Mismetti, France Clinical Cases: 09.15 09.35 09.35 09.55 09.55 10.15 1) Patient on Clopidogrel Presenter: N Rosencher, France 2) Patient with Bleeding Issues Presenter: P Ockelford, New Zealand 3) Patient with a History of VTE Presenter: D Warwick, UK

Auditorium VI & VII

Sponsored with an educational grant from Boehringer Ingelheim.

MEETING LOCATION
Centro de Congressos de Lisboa CCL Praa das Indstrias 1300-307 Lisbon Portugal

Information Desk Opening Times

Congress Centre (CCL) The Information Desk will be located on Level 1 of the CCL and will be open during the Global Thrombosis Forum at the following times: Saturday 17 April 2010 Sunday 18 April 2010 08.00 - 18.30 08.00 - 14.00

Hotels Information Desks will also be located in the lobby of each hotel at the following times: Friday 16 April 2010 Saturday 17 April 2010 Sunday 18 April 2010 For arrivals only 07.00 - 08.30 and 18.00 - 20.00 07.00 - 08.30 and 13.30 - 18.00

Sponsored with an educational grant from Boehringer Ingelheim.